Hypera Pharma

The page presents AAS, a Hypera Pharma brand, including its products, information, and related content.

The page presents Adocyl, a Hypera Pharma brand, including its products, information, and related content.

The page lists Hypera Pharma’s brands and their health, wellness, hygiene, and family care solutions.

The Hypera Pharma blog covers health, wellness, prevention, and self-care topics.

Comprehensive health content covers symptoms, causes, prevention, and care tips for body and mind using reliable information.

Nutrition tips focus on balanced diets, vitamins, minerals, and diets that support well-being and quality of life.

The page compares sugar and sweeteners, highlighting benefits of edulcorants for sweet foods.

A leading brand in its category launches a TV campaign for its vitamin D line with additional nutrients.

The advertising campaign for Brazil’s most famous cold remedy emphasizes tradition and emotional connection.

Hypera Pharma’s awards and recognitions highlight its operations, brands, innovation, and ESG commitments.

Students from São Paulo, Itabuna, and Salvador share how Neo Química’s social impact action aided their careers.

Hypera Pharma’s initiatives support people, talent development, and workplace health and well-being.

Hypera Pharma is one of Brazil’s largest pharmaceutical companies, detailing its history, operations, and health commitment.

Hypera Pharma advances sustainability, social responsibility, and governance, outlining its ESG commitments.

The page explores Hypera Pharma’s research and innovation, showing how science and technology create health solutions.

Hypera Pharma’s initiatives promote health, well-being, inclusion, and social development in communities.

The page provides supplier information for Hypera Pharma, including guidelines, requirements, and relationship channels.

Contact Hypera Pharma through channels for consumers, suppliers, press, and other inquiries.

Hypera Pharma is one of Brazil’s largest pharmaceutical companies, with leading brands and a focus on health and wellness.

The page explains how Hypera Pharma uses cookies across its digital platforms and how users can manage their browsing preferences.

The page describes how Hypera Pharma handles personal data and protects the privacy of consumers and visitors on its digital platforms.

Hypera Pharma’s compliance program outlines integrity principles and reporting channels for concerns.

The terms of use for Hypera Pharma’s digital channels detail access conditions for content and services.

Hypera Pharmaceuticals launches **Semavy**, a semaglutide auto-injector pen, in Brazil’s retail pharmacies. The product targets obesity and diabetes treatment, expanding access to GLP-1 therapies in the country. Regulatory approval follows clinical trials demonstrating efficacy and safety.

Sep 2026valorinternationalNews article

Hypera S.A. releases its Q4 2024 earnings report, detailing financial performance for investors. The company provides a breakdown of key metrics and operational updates for the quarter.

Mar 2025TipRanksNews article

Brazilian pharmaceutical company **EMS** is proposing a merger with rival **Hypera** to form Brazil’s largest drug manufacturer. The deal, announced by both firms, aims to consolidate market share in the country’s pharmaceutical industry. If completed, the combined entity would dominate Brazil’s drug production sector.

Oct 2024PM360News article

Takeda Pharmaceutical sells a portfolio of over-the-counter and non-core products in Latin America to Hypera S.A. for $825 million. The transaction finalizes a deal first announced in March 2020, marking a strategic divestment of select assets. Hypera Pharma expands its Latin American pharmaceutical footprint with the acquisition.

Jan 2021Express PharmaNews article